AU2002366217A1 - Treatment of major depressive disorder using glucocorticoid receptor antagonists - Google Patents

Treatment of major depressive disorder using glucocorticoid receptor antagonists

Info

Publication number
AU2002366217A1
AU2002366217A1 AU2002366217A AU2002366217A AU2002366217A1 AU 2002366217 A1 AU2002366217 A1 AU 2002366217A1 AU 2002366217 A AU2002366217 A AU 2002366217A AU 2002366217 A AU2002366217 A AU 2002366217A AU 2002366217 A1 AU2002366217 A1 AU 2002366217A1
Authority
AU
Australia
Prior art keywords
treatment
receptor antagonists
glucocorticoid receptor
depressive disorder
major depressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366217A
Other languages
English (en)
Other versions
AU2002366217A8 (en
Inventor
Bernardus Wijnand Mathys Marie Peeters
Cornelis Sennef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2002366217A8 publication Critical patent/AU2002366217A8/xx
Publication of AU2002366217A1 publication Critical patent/AU2002366217A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AU2002366217A 2001-11-23 2002-11-18 Treatment of major depressive disorder using glucocorticoid receptor antagonists Abandoned AU2002366217A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01204518 2001-11-23
EP01204518.3 2001-11-23
PCT/EP2002/012854 WO2003043640A2 (en) 2001-11-23 2002-11-18 Treatment of major depressive disorder using glucocorticoid receptor antagonists

Publications (2)

Publication Number Publication Date
AU2002366217A8 AU2002366217A8 (en) 2003-06-10
AU2002366217A1 true AU2002366217A1 (en) 2003-06-10

Family

ID=8181289

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366217A Abandoned AU2002366217A1 (en) 2001-11-23 2002-11-18 Treatment of major depressive disorder using glucocorticoid receptor antagonists

Country Status (5)

Country Link
US (1) US8193172B2 (enExample)
EP (1) EP1453495A2 (enExample)
JP (1) JP2005513024A (enExample)
AU (1) AU2002366217A1 (enExample)
WO (1) WO2003043640A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
JP2009535430A (ja) * 2006-05-02 2009-10-01 コーセプト セラピューティクス， インコーポレイテッド Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
EP3265127B1 (en) 2015-03-02 2024-02-21 Corcept Therapeutics, Inc. Mifepristone and octreotide for use in the treatment of cushing's syndrome in a patient having an adrenocorticotropic hormone (acth)-secreting pancreatic neuroendocrine tumor
AU2016243625B2 (en) 2015-03-30 2020-09-10 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
CA2994422A1 (en) 2015-08-13 2017-02-16 Corcept Therapeutics, Inc. Method for differentially diagnosing acth-dependent cushing's syndrome
MX2018008849A (es) 2016-01-19 2019-01-31 Corcept Therapeutics Inc Diagnostico diferencial de sindrome de cushing ectopico.
US11702443B2 (en) * 2016-10-04 2023-07-18 Pop Test Oncology Llc Therapeutic agents and methods
US11040037B2 (en) * 2016-10-04 2021-06-22 Pop Test Oncology Llc Therapeutic agents and methods
EP3641780B1 (en) 2017-06-20 2025-09-10 Corcept Therapeutics Incorporated Treatment of neuroepithelial tumors using selective glucocorticoid receptor modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
ZA953976B (en) 1994-05-19 1996-01-19 Akzo Nobel Nv 11,21-bisphenyl-19-norpregnane derivatives
IL118974A (en) 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DK1023074T3 (da) * 1997-10-06 2006-11-06 Univ Leland Stanford Junior Fremgangsmåder til behandling af psykose forbundet med glucocorticoid-relateret dysfunktion
OA11877A (en) 1999-04-30 2006-03-29 Pfizer Prod Inc Glucocorticoid receptor modulators.
ES2251505T3 (es) * 2000-08-28 2006-05-01 Pharmacia Corporation Uso de un antagonista del receptor de aldosterona para mejorar la funcion cognoscitiva.
CN1820756A (zh) * 2001-03-23 2006-08-23 科塞普特治疗公司 使用糖皮质激素受体特效拮抗剂治疗压力症的方法

Also Published As

Publication number Publication date
AU2002366217A8 (en) 2003-06-10
US20050020480A1 (en) 2005-01-27
JP2005513024A (ja) 2005-05-12
WO2003043640A2 (en) 2003-05-30
US8193172B2 (en) 2012-06-05
WO2003043640A3 (en) 2004-03-04
EP1453495A2 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
TWI340738B (en) Modulators of the glucocorticoid receptor
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
AU2003251970A8 (en) Modulators of the glucocorticoid receptor and method
AU2002326948A1 (en) Piperizinones as modulators of chemokine receptor activity
SI1379647T1 (sl) Antagonist antiteles sesaläśevega citokina ali njegovega receptorja za zdravljenje alergije
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2002252460A1 (en) Human cytokine receptor
AU2002366217A1 (en) Treatment of major depressive disorder using glucocorticoid receptor antagonists
AU2003279841A1 (en) Uses of human zven antagonists
AU2002351175A1 (en) Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
GB0101447D0 (en) Regulation of glucocorticoid concentration
IL161669A (en) Chemokine receptor antagonists and methods of use thereof
HK1066736A (en) Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
WO2003006609A9 (en) Human cytokine receptor
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain
IL142102A0 (en) Zinc-sensing receptor and methods of treatment of disorders associated herewith
PL375901A1 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2002225030A1 (en) Regulation of human serotonin-like g protein-coupled receptor
AU2002366272A8 (en) Edg-receptor agonist for the treatment of hypertension
IL160551A0 (en) Plaster for the treatment of dysfunctions and disorders of nails
AU2002241216A1 (en) Zinc-sensing receptor and methods of treatment of disorders associated herewith
AU2002364149A1 (en) Novel human g-protein coupled receptor, hgprbmy34, and variants and methods of use thereof
AU2002328399A1 (en) Use of g protein-coupled receptor protein
EP1302204A1 (en) Vanilloid receptor antagonists for the treatment of pathological constriction of airways

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase